Emma Court, Bloomberg

Emma Court

Bloomberg

Contact Emma

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • Bloomberg
  • Pioneer Press
  • Business Insider
  • Business Insider SG
  • Moneyish
  • The Atlantic
  • Cashay
  • Wall Street Journal
  • New York Post

Past articles by Emma:

Remote Work Costs NYC $12 Billion a Year By Killing Big Offices

That translates into big savings for individuals, who are spending nearly $5,000 a year less on meals, shopping and entertainment near work as schedules shift to a new norm. → Read More

Ozempic, trending for weight loss, is in short supply for people with diabetes

The reason for a lack of certain diabetes drugs is unusual: Doctors are prescribing them to non-diabetics who want to use them for weight loss. → Read More

The New York Bagel Wars Have a New Contender: Philadelphia

At Brooklyn’s K’Far, chef Michael Solomonov is bringing in Jerusalem bagels from his Pennsylvania hometown. → Read More

NYC’s 20,000 Migrants Are Fueling the City’s Underground Economy

The influx has spurred a shelter and schools crisis, but new arrivals say what they are after now is work. → Read More

With NYC Shelters Overflowing, City Putting Up Tents for Migrants

The centers are a response to the influx of thousands of asylum seekers many of whom were bussed to the East Coast in recent weeks by the Republican governors. → Read More

Obesity Drug Helps Patients Lose About 20% of Weight, Lilly Says

Eli Lilly & Co.’s obesity drug tirzepatide helped patients on the highest dose shed about 21% of their body weight, or roughly 50 pounds, in a late-stage clinical trial, the company said early Thursday. → Read More

Where Is the Operation Warp Speed for Covid Testing?

An all-out effort paid off in developing vaccines, but America continues to lurch from one wave of the virus to another without a meaningful plan for ongoing surveillance. → Read More

Merck’s Covid Pill Must First Overcome Anti-Vax Misinformation

Unproven claims on social media that ivermectin is effective against coronavirus could trim demand for the drugmaker’s new treatment. → Read More

Covid Pills May Save Lives, But They Won’t End the Pandemic

While new treatments from Pfizer and Merck have the potential to keep people out of the hospital, vaccines are still the best weapon for fighting Covid. → Read More

Harvard Immunologist Champions At-Home Covid Tests to Beat the Pandemic

Michael Mina says the U.S. should be following in the footsteps of Germany and the U.K. in making low-cost, rapid tests readily available to consumers. → Read More

Biden Plans $1 Billion Push to Boost Rapid Covid-19 Testing

The Biden administration will announce a $1 billion purchase of rapid at-home Covid-19 tests on Wednesday, an additional investment geared at expanding the availability of such products in the coming months, a White House official said. → Read More

Three Doses Could Become Standard Covid Regimen, Fauci Says

Three doses of Covid-19 vaccine may become the standard regimen for most people, White House chief medical adviser Anthony Fauci said Thursday at a briefing. → Read More

New Obesity Drug Must Convince Insurers That It’s Worth the Cost

Novo Nordisk’s Wegovy could be a really big hit—if it’s covered. → Read More

Why Some Vaccinated People Still Get Covid

In this week's edition of the Covid Q&A, we look at when a person who has been fully vaccinated still develops Covid-19, or what’s known among epidemiologists as a “breakthrough” infection. In hopes of making this very confusing time just a little less so, each week Bloomberg Prognosis is picking one question sent in by readers and putting it to an expert in the field. This week's question is: → Read More

What the Fresh, New, Latest U.S. Rules on Masks Mean

U.S. authorities have been all over the map when it comes to whether ordinary people should wear masks in the era of the coronavirus. At the start of the pandemic in early 2020, the Centers for Disease Control and Prevention discouraged it in most circumstances, in part to preserve supplies for health workers, before changing its position only in April of that year. One of President Joe Biden’s… → Read More

CDC Says Fully Vaccinated People Can Go Without Masks

Fully vaccinated Americans can do away with wearing masks, the head of the U.S. Centers for Disease Control and Prevention said, the most significant shift in federal guidelines since the start of the pandemic. → Read More

Herd Immunity Is Humanity’s Great Hope, and It’s Proving Elusive

Variants have become so significant that researchers now say ending the pandemic will be gradual, with bumps along the way. → Read More

U.S. Created a Data Disaster With Its Uneven Covid Response

More than a month into a resurgence of the novel coronavirus that has besieged Sun Belt states, flooded hospitals and strained public-health infrastructure, the U.S. still lacks a complete picture of the on-the-ground reality. → Read More

Drugmakers Have Even Less Reason to Fear Price Reform Now

With people hoping for a coronavirus vaccine, Congress has less leverage to rein in the industry. → Read More

Drugmakers Have Even Less Reason to Fear Price Reform Now

With people hoping for a coronavirus vaccine, Congress has less leverage to rein in the industry. → Read More